Skip to content

Image Quality Study of Spectral Precise Image CT 7700

Clinical Study for Spectral Precise Image (SPI) Algorithm

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07108205
Enrollment
126
Registered
2025-08-06
Start date
2025-07-16
Completion date
2025-10-14
Last updated
2025-12-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Body, Cardiac, Head

Keywords

CT, Tomography, Image Quality, Noise reduction

Brief summary

The goal of the study is to evaluate the Image Quality (IQ), and diagnostic confidence of Spectral Precise Image for CT 7700 Scanner as compared with iDose4 as a standard-of-care reference.

Detailed description

Spectral Precise Image is a reconstruction technique where the system uses a trained deep learning neural network to produce an image that reduces noise while improving low contrast detectability and maintaining the appearance of traditional filtered back projection (FBP) images. Spectral Precise Image in Spectral CT 7700 system supports both conventional and spectral reconstructions. The study will use raw data of subjects that are over the age of 22 years and scanned by Philips Spectral CT. Study raw data, following anonymization, will be transferred to Philips for reconstructions, both conventional and spectral images will be reconstructed with iDose4 and with Spectral Precise Image at 100% dose.

Interventions

DEVICEPaired reading analysis

Paired side be side evaluation Each reader will assess- Image Quality (IQ) & Diagnostic Confidence Ratings will be recorded using a 5-point Likert scale

Sponsors

Philips Clinical & Medical Affairs Global
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
22 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* • Subjects scanned by Spectral CT (K203020) according to the department standard of care clinical protocols. * Subjects age \> twenty-two (22) years

Exclusion criteria

* • Scans that the site radiologists have deemed as non-diagnostic image quality in the standard practice (e.g. patient movement) * Scans that are not completed due to technical difficulties

Design outcomes

Primary

MeasureTime frameDescription
Image Quality (IQ) of Spectral Precise Image reconstructions non inferior to iDose conventional images1 dayPrimary Endpoint (Co-Primary endpoints): 1\. The Image Quality (IQ) and diagnostic confidence of Spectral Precise Image reconstructions is at least as good as (non-inferior to) iDose4 for conventional images.
Image Quality (IQ) of Spectral Precise Image reconstructions non-inferior to iDose4 for spectral images of MonoE (MonoE 70Kev for Cardiac and for Body/ MonoE 66KeV for Head).1 dayPrimary Endpoint (Co-Primary endpoints): 2. The Image Quality (IQ) and diagnostic confidence of Spectral Precise Image reconstructions is at least as good as (non-inferior to)-iDose4 for spectral images of MonoE (MonoE 70Kev for Cardiac and for Body/ MonoE 66KeV for Head).

Secondary

MeasureTime frameDescription
Evaluation of the differences in Image Quality (IQ) of Spectral Precise Image reconstructions versus iDose conventional images1 day1\. To evaluate the difference in Image Quality (IQ) and diagnostic confidence between Spectral Precise Image reconstructions for spectral images of MonoE (MonoE 70Kev for Cardiac and for Body/ MonoE 66KeV for Head) and iDose4 for conventional images.
Evaluation of the success rate for Spectral Precise Image reconstruction1 day2\. To evaluate the success rate (%) for Spectral Precise Image reconstructions
Evaluation of the interobserver agreement level for the Co-Primary endpoints1 day3\. The interobserver agreement level for the Co-Primary endpoints is more than 0.8.
Evaluation of images artifacts visualization and preservation of important features1 day4\. Evaluation of images artifacts visualization and preservation of important features and clinical impact on diagnostic ability.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026